ChemDiv Competitors

Since 2001, Provid has created expert medicinal chemistry solutions in drug discovery for clients in the life sciences. As the pharmaceutical industry is undergoing fundamental changes in its business models, Provid is expanding our own offering of core excellence in medicinal chemistry into areas of drug development. Over the past decade, we've helped dozens of our clients with their drug discovery needs and have gained experience in transitioning research programs into development and in managing complex projects with external resources. In addition, we built our own pipeline of proprietary projects through collaborations with academia and not-for-profit foundations and through government grants. We have matured that pipeline with substantial success, including our autoimmune and oncology projects. In the process of doing so, we have developed expertise in other technical areas of early development such as ADME, toxicology, formulation, DMPK, process development, pre-IND studies, and clinical trial design. We have invested in our capabilities to allow us to bring that same expertise directly to the benefit of our customers. We occupy a unique niche in the evolving landscape of drug discovery and development. Now, as customers continue to approach us for our craftsman-level medicinal chemistry, consulting support on due diligence projects, and offers of collaboration on early chemistry projects, we can respond not only with that level of world-class service in medicinal chemistry, but can plan and deliver directly on the downstream steps of their projects, potentially through clinical proof of concept and beyond.

ChemBridge Corporation is a global provider of enabling chemistry products and contract research services for small molecule drug discovery and chemical biology research. ChemBridge’s extensive portfolio includes over 1.3 million diverse and target-focused screening compounds, 14,000 chemical building blocks, 10,000 synthetic macrocycles, our Hit2Lead.com on-line chemical store, and high-end, research-intensive custom library and synthetic/medicinal chemistry services. ChemBridge’s research products and services are supported by an experienced, dedicated and friendly customer service and project management team at our San Diego headquarters and by ChemBridge’s 25-year track record of innovation, quality and deliverability.

CreaGen, Inc. is a drug discovery chemistry CRO providing cost-effective, high quality services to pharmaceutical and biotech companies of all sizes. Our discovery research team helps transform ideas into innovative medicines using extensive experience in lead generation, lead optimization, natural products scaffolds, building block synthesis, custom library development, structure and fragment based drug design, and HTP synthesis and purification. C2I Accelerator, launched summer 2012, is housed within CreaGen, Inc. The incubator allows its' companies access to fully equipped chemistry & biology laboratories as well as leading senior scientists and corporate development consultants. We aim to give start-up companies tools, resources, and a home so they can efficiently build upon their scientific foundation while raising funding to grow their organization.